Univariate logistic regress analysis of factors affecting progression to severe pneumonia showed that the use of Thymalfasin was a protective factor, while elevation of WBC, PCT and CRP was a risk factor. This evidence concerns the gene CRP and susceptibility to pneumonia measurement.